CTLA4 and cancer: Honjo and Allison were awarded the 2018 Nobel Prize for their discovery of programmed death-ligand-1 (PD-L1) and cytotoxic T lymphocyte antigen-4 (CTLA-4), co-stimulatory factors that regulate cancer and autoimmune diseases (15, 16).